alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
[Federal Register Volume 66, Number 94 (Tuesday, May 15, 2001)]
[Rules and Regulations]
[Page 26793]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-12200]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Air Force

32 CFR Part 989


Environmental Impact Analysis Process (EIAP); Correction

AGENCY: Department of the Air Force, DoD.

ACTION: Final rule; correction.

-----------------------------------------------------------------------

SUMMARY: The Department of the Air Force published in the Federal 
Register of March 28, 2001, a document concerning correcting 
amendments. This document corrects the inadvertent change to correcting 
amendment 17.

DATES: Effective on May 15, 2001.

FOR FURTHER INFORMATION CONTACT: Mr. Jack Bush (HQ USAF/ILEB), 1260 Air 
Force Pentagon, Washington, DC 20330-1260, (703) 604-0553.

SUPPLEMENTARY INFORMATION: In FR Doc. 01-7671 published on March 28, 
2001 (66 FR 16868) make the following correction. On page 16868, 
correcting amendment 17, Sec. 989.18, paragraph (a), third to last 
sentence correct ``AF/ILEV'' to read ``USAF/ILEV.''

    Dated: May 10, 2001.
Janet A. Long,
Air Force Federal Register Liaison Officer.
[FR Doc. 01-12200 Filed 5-14-01; 8:45 am]
BILLING CODE 5001-05-P
Case 1:07-cv-05867-PAC Document 4 Filed 07/09/2007 Page 1 of 4
Case 1:07-cv-05867-PAC Document 4 Filed 07/09/2007 Page 2 of 4
Case 1:07-cv-05867-PAC Document 4 Filed 07/09/2007 Page 3 of 4
Case 1:07-cv-05867-PAC Document 4 Filed 07/09/2007 Page 4 of 4
EXHIBIT 99.2

**CERTIFICATION OF CFO PURSUANT TO18 U.S.C. SECTION 1350,AS ADOPTED PURSUANT TOSECTION 906 OFTHE SARBANES-OXLEY ACT OF 2002**

****

            In connection with the Quarterly Report on Form 10-Q of Vanguard Health Systems, Inc. (the “Company”) for the quarterly period ended December 31, 2002, as filed with the Securities andExchange Commission on the date hereof (the “Report”), I, Joseph D. Moore, Executive Vice President, Chief Financial Officer and Treasurer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of theSarbanes-Oxley Act of 2002, that:

            (1)      The Report fully complies with the requirements of Section 13(a) or 15(d)                       of the Securities Exchange Act of 1934; and

            (2)      The information contained in the Report fairly presents, in all material                       respects, the financial condition and results of operations of the Company.

/s/ Joseph D. Moore                             Joseph D. MooreExecutive Vice President, Chief Financial Officer and TreasurerMay 13, 2003

            A signed original of this written statement required by Section 906 has been provided to Vanguard Health Systems, Inc. and will be retained by Vanguard Health Systems, Inc. and furnished to theSecurities and Exchange Commission or its staff upon request.
**EXHIBIT
      32.1**





**CERTIFICATION
      PURSUANT TO**


**18
      U.S.C. SECTION 1350,**


**AS
      ADOPTED PURSUANT TO**


**SECTION
      906 OF THE SARBANES-OXLEY ACT OF 2002**





In
      connection with the Annual Report of Innova Holdings, Inc. (the "Company")
      on
      Form 10-KSB/A for the year ended December 31, 2005 as filed with the Securities
      and Exchange Commission on the date hereof (the "Report"), I, Walter Weisel,
      Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section
      1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002,
      that;





(1)
      The
      Report fully complies with the requirements of section 13(a) or 15(d) of the
      Securities Exchange Act of 1934; and





(2)
      The
      information contained in the Report fairly presents, in all material respects,
      the financial condition and results of operations of the Company.





A
      signed
      original of this written statement required by Section 906 has been provided
      to
      the Company and will be retained by the Company and furnished to the Securities
      and Exchange Commission or its staff upon request.




*/s/* *Walter
                Weisel**Name:
                Walter Weisel**Title:
                  Chief Executive Officer*
                *Date: September 28,
                  2006*
Anne Mitton

DDR Compliance Director 

September 19, 2022 

Assistant Secretary of the Commission for FOIA Matters 

Commodity Futures Trading Commission 

Three Lafayette Centre 

1155 21st Street, NW 

Washington, DC 20581 

Re: FOIA Confidential Treatment Request 

DTCC Data Repository (U.S.) LLC 

55 Water Street 

New York, NY 10041-0099 

Tel: (813) 470-1121 

amitton@dtcc.com

Dear Staff: 

Pursuant to Section 145.9 of the U.S. Commodity Futures Trading Commission (the 

“Commission”) Regulations under the Commodity Exchange Act, as amended, DTCC Data 

Repository (U.S.) LLC (“DDR”) requests that the following document(s) being submitted to the 

Commission and the information contained therein (together, the “Document(s)”), be afforded 

confidential treatment until further notice under the Freedom of Information Act and the 

Commission's Regulations: 

Document(s): 

 DDR Systems Development and Monitoring Procedures

The request set forth in the preceding paragraph also applies to any memoranda, notes, 

transcripts, other writings or materials of any sort whatsoever that are made by, or at the request 

of, any employee of the Commission (or any other federal agency) and which incorporate, 

include or relate to any aspect of the Confidential Material. 

If you have any questions regarding this request, please contact me at (813) 470-1121. 

Very truly yours, 

Anne Mitton

DDR Compliance Director
```

[Congressional Bills 116th Congress]
[From the U.S. Government Publishing Office]
[H.R. 1973 Introduced in House (IH)]

<DOC>

116th CONGRESS
  1st Session
                                H. R. 1973

To amend the Internal Revenue Code of 1986 to provide authority to add 
          additional vaccines to the list of taxable vaccines.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                             March 28, 2019

  Mr. Higgins of New York (for himself and Mr. Kelly of Pennsylvania) 
 introduced the following bill; which was referred to the Committee on 
                             Ways and Means

_______________________________________________________________________

                                 A BILL

 
To amend the Internal Revenue Code of 1986 to provide authority to add 
          additional vaccines to the list of taxable vaccines.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Vaccine Access Improvement Act of 
2019''.

SEC. 2. ADDITION OF NEW VACCINES TO LIST OF TAXABLE VACCINES.

    (a) In General.--Section 4132(a)(1) of the Internal Revenue Code of 
1986 is amended by adding at the end the following new subparagraph:
                    ``(Q) Any vaccine which is not described in any 
                other subparagraph of this paragraph and which is 
                included on the Vaccine Injury Table under section 2114 
                of the Public Health Service Act.''.
    (b) Notification.--Not later than 30 days after the Secretary of 
Health and Human Services adds a vaccine to the Vaccine Injury Table 
pursuant of section 2114 of the Public Health Service Act (42 U.S.C. 
300aa-14), the Secretary shall notify the Secretary of the Treasury, 
the Committee on Health, Education, Labor, and Pensions of the Senate, 
the Committee on Finance of the Senate, the Committee on Energy and 
Commerce of the House of Representatives, and the Committee on Ways and 
Means of the House of Representatives of such designation.
    (c) Effective Date.--
            (1) Sales, etc.--The amendment made by subsection (a) shall 
        apply to sales and uses on or after the date on which the 
        Secretary of Health and Human Services lists any new vaccine 
        pursuant to section 2114 of the Public Health Service Act (42 
        U.S.C. 300aa-14) for purposes of compensation for any vaccine-
        related injury or death through the Vaccine Injury Compensation 
        Trust Fund.
            (2) Deliveries.--For purposes of paragraph (1) and section 
        4131 of the Internal Revenue Code of 1986, in the case of sales 
        on or before the effective date described in such paragraph for 
        which delivery is made after such date, the delivery date shall 
        be considered the sale date.
                                 <all>
```
Case 1:07-cv-05796-SAS Document 7 Filed 07/26/2007 Page 1 of 1
# C_2004194EN.01000501.xml

| 30.7.2004 | EN | Official Journal of the European Union | C 194/5 |
| --- | --- | --- | --- |

30.7.2004

EN

Official Journal of the European Union

C 194/5

---

Summary of Community decisions on marketing authorisations in respect of medicinal products from 15 May 2004 to 15 June 2004

(Published pursuant to Article 12 or Article 34 of Council Regulation (EEC) No 2309/93 (1))

1

(2004/C 194/03)

—   Issuing of a marketing authorisation (Article 12 of Council Regulation (EEC) No 2309/93): accepted

| Date of the decision | Name of the medicinal product | Holder of the marketing authorisation | Number of the entry in the Community Register | Date of notification |
| --- | --- | --- | --- | --- |
| 4.6.2004 | Abilify | Otsuka Pharmaceutical Europe Ltd |
| Commonwealth House |
| 2 Chalkhill Road |
| Hammersmith |
| London W6 8DW |
| United Kingdom |

Date of the decision

Name of the medicinal product

Holder of the marketing authorisation

Number of the entry in the Community Register

Date of notification

4.6.2004

Abilify

Otsuka Pharmaceutical Europe Ltd

Commonwealth House

2 Chalkhill Road

Hammersmith

London W6 8DW

United Kingdom

EU/1/04/276/001-020

8.6.2004

---

(1)  OJ L 214, 24.8.1993, p. 1.

1

---
# Effective 10 days post filing

# Effective 3.1.24
#### The People of the State of New York, Respondent, v Earl Brown, Appellant.

Appeal by the defendant from a judgment of the Supreme Court, Kings County (Pesce, J.), *702rendered May 28, 1987, convicting him of burglary in the first degree, robbery in the first degree, robbery in the second degree and unlawful imprisonment in the second degree (two counts), upon a jury verdict, and imposing sentence.

Ordered that the judgment is affirmed.

A review of the record indicates, contrary to the defendant’s contention, that the court correctly charged the jury on accomplice testimony and the required corroboration thereof. The jury was instructed to view the inherent trustworthiness of the accomplice’s testimony with suspicion, and furthermore was instructed that corroboration by a credible source was necessary *(see,*1 CJI[NY] 7.52, at 337-339).

The defendant’s remaining contentions are either unpreserved for appellate review *(see,*CPL 470.05 [2]) or without merit. Mangano, J. P., Eiber, Sullivan and Balletta, JJ., concur.
Case 1:07-cv-05861-RMB-GWG Document 17 Filed 09/12/2007 Page 1 of 33
Case 1:07-cv-05861-RMB-GWG Document 17 Filed 09/12/2007 Page 2 of 33
Case 1:07-cv-05861-RMB-GWG Document 17 Filed 09/12/2007 Page 3 of 33
Case 1:07-cv-05861-RMB-GWG Document 17 Filed 09/12/2007 Page 4 of 33
Case 1:07-cv-05861-RMB-GWG Document 17 Filed 09/12/2007 Page 5 of 33
Case 1:07-cv-05861-RMB-GWG Document 17 Filed 09/12/2007 Page 6 of 33
Case 1:07-cv-05861-RMB-GWG Document 17 Filed 09/12/2007 Page 7 of 33
Case 1:07-cv-05861-RMB-GWG Document 17 Filed 09/12/2007 Page 8 of 33
Case 1:07-cv-05861-RMB-GWG Document 17 Filed 09/12/2007 Page 9 of 33
Case 1:07-cv-05861-RMB-GWG Document 17 Filed 09/12/2007 Page 10 of 33
Case 1:07-cv-05861-RMB-GWG Document 17 Filed 09/12/2007 Page 11 of 33
Case 1:07-cv-05861-RMB-GWG Document 17 Filed 09/12/2007 Page 12 of 33
Case 1:07-cv-05861-RMB-GWG Document 17 Filed 09/12/2007 Page 13 of 33
Case 1:07-cv-05861-RMB-GWG Document 17 Filed 09/12/2007 Page 14 of 33
Case 1:07-cv-05861-RMB-GWG Document 17 Filed 09/12/2007 Page 15 of 33
Case 1:07-cv-05861-RMB-GWG Document 17 Filed 09/12/2007 Page 16 of 33
Case 1:07-cv-05861-RMB-GWG Document 17 Filed 09/12/2007 Page 17 of 33
Case 1:07-cv-05861-RMB-GWG Document 17 Filed 09/12/2007 Page 18 of 33
Case 1:07-cv-05861-RMB-GWG Document 17 Filed 09/12/2007 Page 19 of 33
Case 1:07-cv-05861-RMB-GWG Document 17 Filed 09/12/2007 Page 20 of 33
Case 1:07-cv-05861-RMB-GWG Document 17 Filed 09/12/2007 Page 21 of 33
Case 1:07-cv-05861-RMB-GWG Document 17 Filed 09/12/2007 Page 22 of 33
Case 1:07-cv-05861-RMB-GWG Document 17 Filed 09/12/2007 Page 23 of 33
Case 1:07-cv-05861-RMB-GWG Document 17 Filed 09/12/2007 Page 24 of 33
Case 1:07-cv-05861-RMB-GWG Document 17 Filed 09/12/2007 Page 25 of 33
Case 1:07-cv-05861-RMB-GWG Document 17 Filed 09/12/2007 Page 26 of 33
Case 1:07-cv-05861-RMB-GWG Document 17 Filed 09/12/2007 Page 27 of 33
Case 1:07-cv-05861-RMB-GWG Document 17 Filed 09/12/2007 Page 28 of 33
Case 1:07-cv-05861-RMB-GWG Document 17 Filed 09/12/2007 Page 29 of 33
Case 1:07-cv-05861-RMB-GWG Document 17 Filed 09/12/2007 Page 30 of 33
Case 1:07-cv-05861-RMB-GWG Document 17 Filed 09/12/2007 Page 31 of 33
Case 1:07-cv-05861-RMB-GWG Document 17 Filed 09/12/2007 Page 32 of 33
Case 1:07-cv-05861-RMB-GWG Document 17 Filed 09/12/2007 Page 33 of 33
I I USDS SDNY I 

Commerce and Industry Plaintiff, 

Insurance Company 

- against - 

U.S. Bank National Defendant. 

Association 

DOCUMENT 1 

1-1 1 .'~r~>,i>\~(-kjIT.~~~l.~D I 

ORDER FOR ADMISSION 

PRO HAC VICE 

ON WRITTEN MOTION 

Upon the motion of Charles E. Dorkey 111 attorney for U.S. Bank National Association 

and said sponsor attorney's affidavit in support; 

IT IS HEREBY ORDERED that 

Applicant's Name: Jeremy Mark Moeser 

Firm Name: McKenna Long & Aldridge LLP 

Address: 303 Peachtree Street., Suite 5300 

Cityistatelzip: Atlanta, GA 30308 

Telephone/Fax: (404) 527-4 156 

Email Address: jrnoeser@mckennalong.corn 

is admitted to practice pro hac vice as counsel for U.S. Bank National Association in the above 

captioned case in the United States District Court for the Southern District of New York. All attorneys 

appearing before this Court are subject to the Local Rules of this Court, including the Rules governing 

discipline of attorneys. If this action is assigned to the Electronic Case Filing (ECF) system, counsel shall 

immediately apply for an ECF password at nysd.uscourts.gov. Counsel shall forward the pro hac vice 

fee to the Clerk of Court. 

Dated: 4~7 

City, Stat : 

yp'iii* nited tates District/- Judge 

-- 

FOR OFFICE USE ONLY. FEE PAID S SDNY RECEIPTU 

SDNY Form Web 1012006 

Case 1:07-cv-05731-JGK-RLE Document 15 Filed 11/15/2007 Page 1 of 1
# C_2021079EN.01002901.xml

| 8.3.2021 | EN | Official Journal of the European Union | C 79/29 |
| --- | --- | --- | --- |

8.3.2021

EN

Official Journal of the European Union

C 79/29

---

Judgment of the General Court of 20 January 2021 — Foundation for the Protection of the Traditional Cheese of Cyprus named Halloumi v EUIPO — M. J. Dairies (BBQLOUMI)

(Case T-328/17 RENV) (1)

(EU trade mark - Opposition proceedings - Application for EU figurative mark BBQLOUMI - Earlier EU collective word mark HALLOUMI - Relative ground for refusal - No likelihood of confusion - Article 8(1)(b) of Regulation (EC) No 207/2009 (now Article 8(1)(b) of Regulation (EU) 2017/1001))

(2021/C 79/37)

Language of the case: English

Parties

Applicant: Foundation for the Protection of the Traditional Cheese of Cyprus named Halloumi (Nicosia, Cyprus) (represented by: S. Malynicz QC, V. Marsland, Solicitor, and S. Barran, Barrister)

Defendant: European Union Intellectual Property Office (represented by: D. Gája and V. Ruzek, acting as Agents)

Other party to the proceedings before the Board of Appeal of EUIPO, intervener before the General Court: M.J. Dairies EOOD (Sofia, Bulgaria) (represented by: D. Dimitrova, avocate)

Re:

Action brought against the decision of the Fourth Board of Appeal of EUIPO of 16 March 2017 (Case R 497/2016-4), relating to opposition proceedings between the Foundation for the Protection of the Traditional Cheese of Cyprus named Halloumi and M. J. Dairies.

Operative part of the judgment

The Court:

| 1. | Dismisses the action; |
| --- | --- |

1.

Dismisses the action;

| 2. | Orders Foundation for the Protection of the Traditional Cheese of Cyprus named Halloumi to pay the costs relating to the proceedings instituted before the General Court and to the proceedings on the appeal before the Court of Justice. |
| --- | --- |

2.

Orders Foundation for the Protection of the Traditional Cheese of Cyprus named Halloumi to pay the costs relating to the proceedings instituted before the General Court and to the proceedings on the appeal before the Court of Justice.

---

(1)  OJ C 239, 24.7.2017.

---
[Federal Register Volume 66, Number 98 (Monday, May 21, 2001)]
[Notices]
[Pages 27986-27987]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-12673]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Substance Abuse and Mental Health Services Administration


Agency Information Collection Activities: Submission for OMB 
Review; Comment Request

    Periodically, the Substance Abuse and Mental Health Services 
Administration (SAMHSA) will publish a list of information collection 
requests under OMB review, in compliance with the Paperwork Reduction 
Act (44 U.S.C. Chapter 35). To request a copy of these documents, call 
the SAMHSA Reports Clearance Officer on (301) 443-7978.
    Confidentiality of Alcohol and Drug Abuse Patient Records--(OMB No. 
0930-0092, Extension, no change)-- Statute (42 USC 290dd-2) and 
regulations (42 CFR Part 2) require Federally conducted, regulated, or 
directly or indirectly assisted alcohol and drug abuse programs to keep 
alcohol and drug abuse patient records confidential. Information 
requirements

[[Page 27987]]

are (1) written disclosure to patients about Federal laws and 
regulations that protect the confidentiality of each patient, and (2) 
documenting ``medical personnel'' status of recipients of a disclosure 
to meet a medical emergency. The annual burden estimates for these 
requirements are summarized in the table below.

----------------------------------------------------------------------------------------------------------------
                                                      Annual       Responses per    Burden per
                                                     responses      respondents      response      Annual burden
----------------------------------------------------------------------------------------------------------------
Disclosure 42 CFR 2.22..........................          11,250         130.175  ..............         255,938
Recordkeeping 42 CFR 2.51.......................          11,250               2            .17            3,938
                                                 ---------------------------------------------------------------
      Total.....................................          11,250  ..............  ..............         259,876
----------------------------------------------------------------------------------------------------------------

    Written comments and recommendations concerning the proposed 
information collection should be sent within 30 days of this notice to: 
Stuart Shapiro, Human Resources and Housing Branch, Office of 
Management and Budget, New Executive Office Building, Room 10235, 
Washington, D.C. 20503.

    Dated: May 14, 2001.
Richard Kopanda,
Executive Officer, SAMHSA.
[FR Doc. 01-12673 Filed 5-18-01; 8:45 am]
BILLING CODE 4162-20-U
#### UNITED STATES of America, Plaintiff-Appellee, v. Joseph ZIADEH, Defendant-Appellant.

No. 13-6176.

United States Court of Appeals, Fourth Circuit.

Submitted: May 20, 2013.

Decided: May 23, 2013.

Joseph Ziadeh, Appellant Pro Se. Robert P. McIntosh, Assistant United States Attorney, Richmond, Virginia, for Appel-lee.

Before WILKINSON, GREGORY, and SHEDD, Circuit Judges.

Affirmed by unpublished PER CURIAM opinion.

Unpublished opinions are not binding precedent in this circuit.

PER CURIAM:

Joseph Ziadeh appeals the district court’s order denying (1) his motion for reconsideration of a previous order granting the receiver’s application for compensation; and (2) his Fed.R.Civ.P. 60(b)(3) motion for reconsideration of the final restitution order entered in his criminal proceedings. We have reviewed the record and find no reversible error. Accordingly, we affirm for the reasons stated by the district court. *United States v. Ziadeh,*No. 3:02-cr-00273-HEH-l (E.D.Va. Jan. 31, 2013). We dispense with oral argument because the facts and legal contentions are adequately presented in the materials before this court and argument would not aid the decisional process.

*AFFIRMED.*
Case 1:07-cv-04462-AKH     Document 22      Filed 09/12/2007     Page 1 of 3

Case 1:07-cv-04462-AKH     Document 22      Filed 09/12/2007     Page 2 of 3

Case 1:07-cv-04462-AKH     Document 22      Filed 09/12/2007     Page 3 of 3
**Exhibit 23.1**

 

**CONSENT OF INDEPENDENT AUDITORS**

 

The Board of Directors

GE Life and Annuity Assurance Company 

 

We consent to incorporation by reference in the Registration Statements (No. 333-67902, No. 333-69620 and No.333-69786) on Form S-1 of GE Life and Annuity Assurance Company of our reports dated February 7, 2003, relating to the consolidated balance sheets of GE Life and Annuity Assurance Company and subsidiary as of December 31, 2002, and 2001, and therelated consolidated statements of income, shareholders’ interest, and cash flows for each of the years in the three-year period ended December 31, 2002, and all related schedules, which reports appear in the December 31, 2002 annual report onForm 10-K of GE Life and Annuity Assurance Company. Our reports refer to a change in the method of accounting for goodwill and other intangible assets in 2002 and derivative instruments and hedging activities in 2001. 

 

/s/ KPMG LLP 

Richmond, Virginia 

March 5, 2003